Journal article · 2021 · Open access

Difference in Estimation of Side Effects of Chemotherapy between Physicians and Patients with Early-Stage Breast Cancer: The Use of Patient Reported Outcomes (PROs) in the Evaluation of Toxicity in Everyday Clinical Practice

Mirjana Pavlović, Robert Šeparović, Ana Tečić Vuger, Ljubica Vazdar

Cancers, 13(23), 5922 · Published 25 November 2021 · DOI 10.3390/cancers13235922

Open PDFView at the publisherCite this paper

In brief

“Difference in Estimation of Side Effects of Chemotherapy between Physicians and Patients with Early-Stage Breast Cancer: The Use of Patient Reported Outcomes (PROs) in the Evaluation of Toxicity in Everyday Clinical Practice” is a 2021 journal article by Mirjana Pavlović and 3 co-authors, published in Cancers. OpenAlex counts 11 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Cancers.

Citations
11
Most cited in
2023 (4)
Field-weighted impact
0.64
References
16
Authors
4

Abstract

Knowledge about the patient's experience and perception of side effects and their impact on daily life is crucial for the adequate planning of interventions to provide the highest attainable levels of quality of life during oncology treatment. We conducted a study on consecutive samples of 69 early breast cancer patients treated with four cycles of neoadjuvant or adjuvant anthracycline-based chemotherapy. Patients completed the questionnaire about side effects experienced after the previous cycle of chemotherapy. The questionnaire was a modified PRO for the evaluation of treatment toxicity consisting of 18 questions related to the very common and common side effects of doxorubicin and cyclophosphamide, valued from 0 to 3 according to the subjective assessment of the patient. During the same cycles of therapy, data were also collected by the physician who completed a questionnaire consisting of the same questions as the questionnaire for patients, on the same scale. Most of the side effects reported by patients were mild to moderate in intensity, while physicians reported side effects much less frequently. The results also indicated a disproportionate reporting, in which physicians reported statistically significantly fewer side effects than patients. This study reported a level of disagreement between patients and physicians in the experience of therapy toxicity. In conclusion, use of PRO in clinical practice can help us avoid physician subjectiveness in the estimation of side effects and determine the group of patients who can benefit from additional and individualized supportive care measures, which could lead to better adherence to therapy and ultimately best outcomes.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Pavlović, M., Šeparović, R., Vuger, A. T., & Vazdar, L. (2021). Difference in Estimation of Side Effects of Chemotherapy between Physicians and Patients with Early-Stage Breast Cancer: The Use of Patient Reported Outcomes (PROs) in the Evaluation of Toxicity in Everyday Clinical Practice. Cancers, 13(23), 5922. https://doi.org/10.3390/cancers13235922

MLA 9

Pavlović, Mirjana, et al. “Difference in Estimation of Side Effects of Chemotherapy between Physicians and Patients with Early-Stage Breast Cancer: The Use of Patient Reported Outcomes (PROs) in the Evaluation of Toxicity in Everyday Clinical Practice.” Cancers, vol. 13, no. 23, 2021, p. 5922. https://doi.org/10.3390/cancers13235922.

Chicago

Pavlović, Mirjana, Robert Šeparović, Ana Tečić Vuger, and Ljubica Vazdar. 2021. “Difference in Estimation of Side Effects of Chemotherapy between Physicians and Patients with Early-Stage Breast Cancer: The Use of Patient Reported Outcomes (PROs) in the Evaluation of Toxicity in Everyday Clinical Practice.” Cancers 13 (23): 5922. https://doi.org/10.3390/cancers13235922.

Harvard

Pavlović, M. et al. (2021) ‘Difference in Estimation of Side Effects of Chemotherapy between Physicians and Patients with Early-Stage Breast Cancer: The Use of Patient Reported Outcomes (PROs) in the Evaluation of Toxicity in Everyday Clinical Practice’, Cancers, 13(23), p. 5922. doi:10.3390/cancers13235922.

IEEE

M. Pavlović, R. Šeparović, A. T. Vuger, and L. Vazdar, “Difference in Estimation of Side Effects of Chemotherapy between Physicians and Patients with Early-Stage Breast Cancer: The Use of Patient Reported Outcomes (PROs) in the Evaluation of Toxicity in Everyday Clinical Practice,” Cancers, vol. 13, no. 23, p. 5922, 2021, doi: 10.3390/cancers13235922.

BibTeX

@article{pavlovic2021difference,
  title     = {{Difference in Estimation of Side Effects of Chemotherapy between Physicians and Patients with Early-Stage Breast Cancer: The Use of Patient Reported Outcomes (PROs) in the Evaluation of Toxicity in Everyday Clinical Practice}},
  author    = {Pavlović, Mirjana and Šeparović, Robert and Vuger, Ana Tečić and Vazdar, Ljubica},
  journal   = {Cancers},
  year      = {2021},
  volume    = {13},
  number    = {23},
  pages     = {5922},
  doi       = {10.3390/cancers13235922},
  url       = {https://doi.org/10.3390/cancers13235922}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202211
202344
202422
202544

Its field-weighted citation impact is 0.64: it has been cited 0.64 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Cancer survivorship and care

  • patient-reported outcomes
  • chemotherapy side effects
  • early breast cancer
  • anthracycline chemotherapy
  • doxorubicin
  • cyclophosphamide
  • patient-physician agreement
  • supportive care

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Pavlović, M., Šeparović, R., Vuger, A. T., & Vazdar, L. (2021). Difference in Estimation of Side Effects of Chemotherapy between Physicians and Patients with Early-Stage Breast Cancer: The Use of Patient Reported Outcomes (PROs) in the Evaluation of Toxicity in Everyday Clinical Practice. Cancers, 13(23), 5922. https://doi.org/10.3390/cancers13235922

How many times has this paper been cited?

11 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cancers: sign in and open the PDF from this page.

Who wrote this paper?

Mirjana Pavlović, Robert Šeparović, Ana Tečić Vuger, Ljubica Vazdar.

What is the DOI of this paper?

10.3390/cancers13235922, permanently at https://doi.org/10.3390/cancers13235922. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.